查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612622

血液檢測市場：按產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

Blood Testing Market by Product (Instruments, Reagents & kits, Software), Test Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血液檢測市場價值為1000.2億美元，預計到2024年將達到1060.1億美元，複合年成長率為6.48%，到2030年將達到1553.1億美元。

血液檢測市場包括對血液樣本進行廣泛的實驗室分析，用於診斷和監測疾病、評估健康狀況以及確定治療策略。血液檢測的需求源自於其在預防保健、疾病早期發現、治療監測和精準醫療方面的重要角色。其應用涵蓋多個領域，包括血液學、內分泌學、腫瘤學和感染疾病學。血液檢測的主要最終使用者是醫院、診斷實驗室、研究機構和居家醫療機構。該市場受到成長要素的顯著影響，例如慢性病患病率上升、健康意識提高、家庭檢測等診斷技術的進步以及政府促進篩檢計劃的舉措。快速就地檢驗和微創技術的發展，以及用於資料分析和個人化醫療的人工智慧和機器學習的整合，正在出現最新的趨勢。公司可以透過投資於創新技術的研發以及與生物技術公司的策略聯盟來抓住這些機會。然而，市場成長面臨嚴格的法律規範、先進測試技術的高成本以及與資料管理相關的隱私問題等限制。此外，需要熟練的專業人員執行和解釋複雜的測試也對市場擴張提出了挑戰。創新和研究將致力於開發具有成本效益、快速且準確的測試解決方案，例如微流體和奈米診斷平台，這可以提高已開發地區和發展中地區的可及性。市場的特點是技術快速進步和競爭動態，需要不斷創新並適應新趨勢和挑戰。為了保持競爭力，公司應加強技術力和策略聯盟，並專注於開發可擴展的解決方案並在服務不足的地區進行地理擴張。

主要市場統計
基準年[2023] 1000.2億美元
預計年份 [2024] 1060.1億美元
預測年份 [2030] 1553.1億美元
複合年成長率（%） 6.48%

市場動態：揭示快速發展的血液檢測市場的關鍵市場洞察

供需的動態交互作用正在改變血液檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 自體免疫疾病的盛行率和加強護理的需要
    • 政府在血液檢測篩檢宣傳活動中的舉措
    • 全球血液檢測設施大幅擴張
  • 市場限制因素
    • 原料成本變動與產品召回問題
  • 市場機會
    • 家庭醫療保健和遠端醫療的快速採用
    • 血液檢測產品的進展
  • 市場挑戰
    • 皮膚穿刺不準確、血液檢測產品安全問題

波特五力：駕馭血液檢測市場的策略工具

波特的五力框架是了解血液檢測市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血液檢測市場的外部影響

外部宏觀環境因素對血液檢測市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血液檢測市場的競爭狀況

對血液檢測市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血液檢測市場供應商績效評估

FPNV定位矩陣是評估血液檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血液檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，血液檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個體自體自體免疫疾病的盛行率以及加強護理的需要
      • 政府推出驗血健康檢查宣傳活動
      • 世界各地血液檢測設施的顯著擴張
    • 抑制因素
      • 原料成本波動與產品召回問題
    • 機會
      • 家庭醫療保健和遠端醫療的快速採用
      • 血液檢測產品的進展
    • 任務
      • 與血液檢測產品相關的皮膚穿刺不準確和安全問題
  • 市場區隔分析
    • 類型：血液檢查中基本代謝組的顯著滲透
    • 應用：增加血液檢測套組在自體免疫疾病診斷的使用
    • 最終用戶：血液檢測產品在居家照護環境中傳播的開始
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血液檢測市場：依產品

  • 裝置
  • 試劑和套件
  • 軟體

第7章按測試類型分類的血液檢測市場

  • 基礎代謝組
  • 全血球計數測試
  • 完整代謝組
  • 電解質板

第8章血液檢測市場：依應用分類

  • 過敏
  • 自體免疫疾病
  • 癌症/非癌症血液疾病
  • 內分泌系統疾病
  • 心臟病

第9章血液檢測市場：依最終用戶分類

  • 血庫
  • 診斷中心
  • 醫院/診所
  • 病理實驗室

第10章美洲血液檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太血液檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的血液檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Quest Diagnostics 宣布推出 P-Tau217 血液生物標記物，用於阿茲海默症風險評估和診斷支持
    • 巴布森診斷公司推出創新的零售血液檢測服務
    • 日本Eisai透過對 C2N Diagnostics 的策略性投資加強阿茲海默症檢測
  • 戰略分析和建議

公司名單

  • A. Menarini Diagnostics srl
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson & Company
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Novo Nordisk A/S
  • Omnipod by Insulet Corporation
  • Quest Diagnostic
  • Randox Laboratories Ltd.
  • Siemens AG
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC
  • Trividia Health, Inc.
  • Ypsomed AG
Product Code: MRR-144C638C91DF

The Blood Testing Market was valued at USD 100.02 billion in 2023, expected to reach USD 106.01 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 155.31 billion by 2030.

The blood testing market encompasses a wide range of laboratory analyses conducted on blood samples to diagnose and monitor diseases, assess health status, and guide treatment decisions. The necessity of blood testing arises from its crucial role in preventive healthcare, early disease detection, therapy monitoring, and precision medicine. Its applications extend across multiple disciplines, including hematology, endocrinology, oncology, and infectious diseases, among others. The primary end-users of blood testing are hospitals, diagnostics laboratories, research institutions, and homecare settings. The market is significantly influenced by growth factors such as the rising prevalence of chronic diseases, increasing health awareness, advancements in diagnostic technologies like home-based testing, and government initiatives promoting screening programs. Recent opportunities emerge from the integration of AI and machine learning for data analysis and personalized medicine, along with the development of rapid point-of-care testing and minimally invasive technologies. Companies can seize these opportunities by investing in R&D focused on innovative technologies and strategic partnerships with biotech firms. However, market growth faces limitations such as stringent regulatory frameworks, high costs of advanced testing technologies, and privacy concerns related to data management. Additionally, the need for skilled professionals to conduct and interpret complex tests can challenge market expansion. Innovations and research are best directed towards the development of cost-effective, rapid, and accurate testing solutions, like microfluidic and nano-diagnostic platforms, that can enhance accessibility in both developed and developing regions. The market is characterized by rapid technological advancements and competitive dynamics, necessitating continuous innovation and adaptation to emerging trends and challenges. To maintain a competitive edge, firms should focus on developing scalable solutions and expanding their geographical footprint in underserved regions, alongside enhancing their technological capabilities and strategic alliances.

KEY MARKET STATISTICS
Base Year [2023] USD 100.02 billion
Estimated Year [2024] USD 106.01 billion
Forecast Year [2030] USD 155.31 billion
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Testing Market

The Blood Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of autoimmune disorders among individuals and need for enhanced care
    • Government initiatives in blood testing checkup campaigns
    • Significant expansion of blood testing facilities worldwide
  • Market Restraints
    • Changing costs of raw materials and issues of product recalls
  • Market Opportunities
    • Rapid adoption of home-based healthcare and telemedicine
    • Advancements in blood testing products
  • Market Challenges
    • Inaccuracy in skin puncture and safety issues associated with blood testing products

Porter's Five Forces: A Strategic Tool for Navigating the Blood Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Testing Market

A detailed market share analysis in the Blood Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Testing Market

A strategic analysis of the Blood Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., bioMerieux S.A., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents & kits, and Software.
  • Based on Test Type, market is studied across Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels, and Electrolyte Panels.
  • Based on Application, market is studied across Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders, Endocrine System Disorders, and Heart Diseases.
  • Based on End-User, market is studied across Blood Banks, Diagnostic Centers, Hospital & Clinics, and Pathology Labs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
      • 5.1.1.2. Government initiatives in blood testing checkup campaigns
      • 5.1.1.3. Significant expansion of blood testing facilities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Changing costs of raw materials and issues of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
      • 5.1.3.2. Advancements in blood testing products
    • 5.1.4. Challenges
      • 5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
    • 5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
    • 5.2.3. End-User: Emerging penetration of blood testing products in home care settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & kits
  • 6.4. Software

7. Blood Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Basic Metabolic Panels
  • 7.3. Complete Blood Count Tests
  • 7.4. Complete Metabolic Panels
  • 7.5. Electrolyte Panels

8. Blood Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Allergies
  • 8.3. Autoimmune Diseases
  • 8.4. Cancer/Noncancerous Blood Disorders
  • 8.5. Endocrine System Disorders
  • 8.6. Heart Diseases

9. Blood Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Diagnostic Centers
  • 9.4. Hospital & Clinics
  • 9.5. Pathology Labs

10. Americas Blood Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support
    • 13.3.2. Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service
    • 13.3.3. Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l.
  • 2. Abbott Laboratories
  • 3. ACON Laboratories, Inc.
  • 4. ARKRAY, Inc.
  • 5. B. Braun Melsungen AG
  • 6. Becton Dickinson & Company
  • 7. Bio-Rad Laboratories Inc.
  • 8. bioMerieux S.A.
  • 9. Danaher Corporation
  • 10. F. Hoffmann-La Roche AG
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medtronic PLC
  • 13. Merck KGaA
  • 14. Nipro Corporation
  • 15. Nova Biomedical Corporation
  • 16. Novo Nordisk A/S
  • 17. Omnipod by Insulet Corporation
  • 18. Quest Diagnostic
  • 19. Randox Laboratories Ltd.
  • 20. Siemens AG
  • 21. Terumo Corporation
  • 22. Thermo Fisher Scientific, Inc.
  • 23. Trinity Biotech PLC
  • 24. Trividia Health, Inc.
  • 25. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. BLOOD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023